<DOC>
	<DOCNO>NCT01129518</DOCNO>
	<brief_summary>This open label randomise control study evaluate induction immunity follow vary schedule vaccination glyco-conjugate Neisseria meningitidis serogroup C ( MenC ) vaccines infancy . 498 infant enrol multi-centre trial . Participants receive either 0 , 1 , 2 priming dos MenC-CRM197 conjugate vaccine 1 prim dose MenC-TT conjugate vaccine first year life , group receive dose combination Hib-MenC-TT vaccine 12 month , well concurrent routine vaccination . All group also divide 2 group receive routine vaccine either consistent alternate limbs ass immune response concurrent infant routine immunisation administer consistent versus alternate limb . Immune response assess 5 , 12 , 12months +6 day , 13 24 month age .</brief_summary>
	<brief_title>Can Reduce Number Vaccine Injections Children ?</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male female infant age 612 week time first vaccination bear 37 42 week gestation Infants know free medical problem determine medical history clinical examination Parents guardians willing child participate would expect comply requirement protocol Parents/guardians give informed consent child 's participation study History invasive meningococcal C disease Previous vaccination meningococcal serogroup C disease Planned administration/administration vaccine , since birth , study vaccine ( exception oral rotavirus vaccine , Hepatitis B vaccine BCG ) . Receipt investigational vaccines/drugs , vaccine use study , within 30 day prior receive first dose vaccine plan use study period Confirmed suspect immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection . A family history congenital hereditary immunodeficiency . Receipt 2 week immunosuppressant immune modify drug , ( e.g . prednisolone &gt; 0.5mg/kg/day ) History allergy component vaccine . Major congenital defect serious chronic illness . History neurologic disorder seizures Acute disease time recruitment define presence moderate severe illness without fever ( exception minor illnesses diarrhoea , mild upper respiratory infection without fever ) . In situation enrolment postpone participant recover . Administration immunoglobulins and/or blood product since birth plan administration study period Parents plan move geographical area study would conduct .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>meningococcal serogroup C</keyword>
	<keyword>vaccine</keyword>
	<keyword>conjugate</keyword>
</DOC>